Cargando…

Needs and Expectations of Patients with Erectile Dysfunction: An Update on Pharmacological Innovations in Phosphodiesterase Type 5 Inhibition with Focus on Sildenafil

INTRODUCTION: Phosphodiesterase type 5 inhibitors (PDE5-Is) have an excellent efficacy and tolerability profile and remain the first-line choice for the treatment of erectile dysfunction (ED). However, ED is still an underdiagnosed and undertreated condition, and many men prematurely discontinue the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jannini, Emmanuele A., Droupy, Stéphane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6377427/ https://www.ncbi.nlm.nih.gov/pubmed/30522978 http://dx.doi.org/10.1016/j.esxm.2018.10.005

Ejemplares similares

COVID-19 and Erectile Dysfunction: Endothelial Dysfunction and Beyond
por: Sansone, Andrea, et al.
Publicado: (2021)

Patient preference and satisfaction in erectile dysfunction therapy: a comparison of the three phosphodiesterase-5 inhibitors sildenafil, vardenafil and tadalafil
por: Raheem, Amr Abdel, et al.
Publicado: (2009)

Proniosomal Gel-Loaded Phosphodiesterase Inhibitors (Sildenafil, Vardenafil, and Tadalafil): Prospects for Topical Penile Therapy of Tadalafil for Treatment of Erectile Dysfunction
por: Mohamed, Soad A., et al.
Publicado: (2023)

Sildenafil in the treatment of erectile dysfunction: an overview of the clinical evidence
por: Hatzimouratidis, Konstantinos
Publicado: (2006)

Endothelial Dysfunction, Erectile Dysfunction and Phosphodiesterase 5 Inhibitors. An Update of the Current Data and Future Perspectives
por: Konstantinopoulos, Angelis, et al.
Publicado: (2007)

Assessment of a New Formulation of Sildenafil on Common Practice: An Observational Study
por: Droupy, Stéphane, et al.
Publicado: (2022)

Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond
por: Ghofrani, Hossein A., et al.
Publicado: (2006)

A comparison of the available phosphodiesterase-5 inhibitors in the treatment of erectile dysfunction: a focus on avanafil
por: Evans, Jeffery D, et al.
Publicado: (2015)

Long-term safety and effectiveness of sildenafil citrate in men with erectile dysfunction
por: McMurray, James G, et al.
Publicado: (2007)

Coronary artery flow reserve in diabetics with erectile dysfunction using sildenafil
por: Dietz, Ulrich, et al.
Publicado: (2003)

Effect of periodic sildenafil dosage on intraocular pressure in patients with erectile dysfunction
por: Nazari, Alireza, et al.
Publicado: (2017)

Survey on Sildenafil, Tadalafil, and Vardenafil Concentrations in Food Supplements for Erectile Dysfunction
por: Petkova-Gueorguieva, Elina, et al.
Publicado: (2022)

An open-label, multicenter, randomized, crossover study comparing sildenafil citrate and tadalafil for treating erectile dysfunction in Chinese men naïve to phosphodiesterase 5 inhibitor therapy
por: Bai, Wen-Jun, et al.
Publicado: (2015)

Sildenafil citrate can improve erectile dysfunction among chronic hemodialysis patients
por: Ghafari, A., et al.
Publicado: (2010)

Erectile dysfunction and heart failure: the role of phosphodiesterase type 5 inhibitors
por: Al-Ameri, H, et al.
Publicado: (2009)

Preference for and adherence to oral phosphodiesterase-5 inhibitors in the treatment of erectile dysfunction
por: Giannitsas, Konstantinos, et al.
Publicado: (2008)

Chronic Low Dosing of Phosphodiesterase Type 5 Inhibitor for Erectile Dysfunction
por: Sung, Hyun Hwan, et al.
Publicado: (2012)

The devil is in the details: an analysis of the subtleties between phosphodiesterase inhibitors for erectile dysfunction
por: Smith-Harrison, L.I., et al.
Publicado: (2016)

Pathophysiology of visual disorders induced by phosphodiesterase inhibitors in the treatment of erectile dysfunction
por: Moschos, Marilita M, et al.
Publicado: (2016)

Use of sildenafil or other phosphodiesterase inhibitors and risk of melanoma
por: Pottegård, Anton, et al.
Publicado: (2016)

Sildenafil (Viagra) for male erectile dysfunction: a meta-analysis of clinical trial reports
por: Moore, RA, et al.
Publicado: (2002)

A meta-analysis on efficacy and tolerability of sildenafil for erectile dysfunction in patients with diabetes mellitus
por: Shah, P. C., et al.
Publicado: (2018)

EDEUS, a Real-Life Study on the Users of Phosphodiesterase Type 5 Inhibitors: Prevalence, Perceptions, and Health Care-Seeking Behavior Among European Men With a Focus on 2nd-Generation Avanafil
por: Corona, Giovanni, et al.
Publicado: (2017)

The Sentiment Analysis of Tweets as a New Tool to Measure Public Perception of Male Erectile and Ejaculatory Dysfunctions
por: Sansone, Andrea, et al.
Publicado: (2019)

Bilateral Simultaneous Nonarteritic Anterior Ischemic Optic Neuropathy after Ingestion of Sildenafil for Erectile Dysfunction
por: Tarantini, Anna, et al.
Publicado: (2012)

Direct comparison of tadalafil with sildenafil for the treatment of erectile dysfunction: a systematic review and meta-analysis
por: Gong, Binbin, et al.
Publicado: (2017)

Efficacy of the Orally Disintegrating Strip Sildenafil for the Treatment of Erectile Dysfunction: A Prospective, Randomized Trial
por: Sangkum, Premsant, et al.
Publicado: (2021)

Effect of the Phosphodiesterase 5 Inhibitor Sildenafil on Ischemia-Reperfusion-Induced Muscle Mitochondrial Dysfunction and Oxidative Stress
por: Tetsi, Liliane, et al.
Publicado: (2019)

“Mask up to keep it up”: preliminary evidence of the association between erectile dysfunction and covid-19
por: Sansone, Andrea, et al.
Publicado: (2022)

Lifestyle modifications and erectile dysfunction: what can be expected?
por: Maiorino, Maria Ida, et al.
Publicado: (2015)

Combined intracavernous vasoactive drugs and sildenafil citrate in treatment of severe erectile dysfunction not responding to on-demand monotherapy
por: Al-Adl, Ahmed M., et al.
Publicado: (2011)

The effects of combined free radical scavenger and sildenafil therapy on age-associated erectile dysfunction: An animal model
por: Kovac, Jason R., et al.
Publicado: (2014)

Evaluation of Serum/Urine Genomic and Metabolomic Profiles to Improve the Adherence to Sildenafil Therapy in Patients with Erectile Dysfunction
por: Rocca, Maria Santa, et al.
Publicado: (2020)

Comparison of the Erectile Dysfunction Drugs Sildenafil and Tadalafil Using Patient Medication Reviews: Topic Modeling Study
por: Kim, Maryanne, et al.
Publicado: (2022)

Erectile Dysfunction: Pharmacological Pathways with Understudied Potentials
por: Adam, Doaa R., et al.
Publicado: (2022)

Phosphodiesterase type 5 inhibitors as a treatment for erectile dysfunction: Current information and new horizons
por: Ferguson, James E., et al.
Publicado: (2013)

The SIAMS-ED Trial: A National, Independent, Multicentre Study on Cardiometabolic and Hormonal Impairment of Men with Erectile Dysfunction Treated with Vardenafil
por: Isidori, Andrea M., et al.
Publicado: (2014)

Advanced hydrogels: New expectation for the repair of organic erectile dysfunction
por: Ren, Yan, et al.
Publicado: (2023)

Evaluation of the effect of sildenafil and/or doxazosin on Benign prostatic hyperplasia–related lower urinary tract symptoms and erectile dysfunction
por: Abolyosr, Ahmed, et al.
Publicado: (2013)

Comparison of the efficacy and safety of low-intensity extracorporeal shock wave therapy versus on-demand sildenafil for erectile dysfunction
por: Lei, Qi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_49dc7ch3uftr71btpdvk30l7d9